NDAINTRAVENOUSPOWDER
Approved
Apr 2015
Lifecycle
Peak
Competitive Pressure
30/100
Mechanism of Action
12.1 Mechanism of Action Meropenem is an antibacterial drug [see ]. 12.2 Pharmacodynamics The percentage of time of a dosing interval that unbound plasma concentration of meropenem exceeds the meropenem minimum inhibitory concentration (MIC) against the infecting organism has been shown to best…
Indications (17)
complicated skinskin structure infections (cSSSI) due to Staphylococcus aureus (methicillin-susceptible isolates only)Streptococcus pyogenesStreptococcus agalactiaeviridans group streptococciEnterococcus faecalis (vancomycin-susceptible isolates only)Pseudomonas aeruginosaEscherichia coliProteus mirabilisBacteroides fragilisPeptostreptococcus speciescomplicated appendicitisperitonitis caused by viridans group streptococciKlebsiella pneumoniaebacterial meningitis caused by Haemophilus influenzaeNeisseria meningitidispenicillin-susceptible isolates of Streptococcus pneumoniae